Russia has developed the first MRNC vaccine against cancer-its use has begun in patients with melanoma

Russia announced the development The world’s first vaccine against cancerwhich in the coming months will begin to be used for patients with melanoma.

The new development is called “Enteromix” and is created using technology MRNAconsidering individual genetic characteristics of each patient.

? ?? Russia to Begin Human Trials for Cancer Vaccine?, Rolled Out to Patients for Free.

Russia’s New Mrna Cancer Vaccine? Launching in 2025 – A Breakthrough in Cancer Treatment pic.twitter.com/6H4RA4MTE4

– Sumit (@sumithansd) August 3, 2025

Head of the National Research Center for Epidemiology and Microbiology named after N.F. Gamaley Alexander Ginzburg He said that the vaccine is intended exclusively for cancer patients and is developed for a particular person.

Clinical trials and first patients

According to Ginzburg, the Ministry of Health of the Russian Federation has already approved the test plan: the vaccine will be applied Experimental in a group of patients with melanoma in cooperation with Research oncology Institute. P.A. Herzen And National Medical Research Center for Oncology. N.N. Blokhina.

Russia is set to launch Human Tritreaking Cancer Vaccine, Aiming to Make Itely Avalable to the Public.

Back in December, Russian Scientists Announced They Had Developed a Therapeutic Mrna-Based Treatment Specially Designed to Fight Cancer.

The government … pic.twitter.com/r6kavsprhm

– Shadow of Ezra (@shadowofezra) August 3, 2025

The start of the process is scheduled for the near future, and the goal is Early introduction Vaccines for patients who have exhausted other treatment methods.

Individual approach and new concept of therapy

The vaccine is based on the so -called “Neoantigens”created personally for each patient.

Unlike standard drugs, it is not intended for mass use: the course is developed exclusively for one person.

According to the candidate of biological sciences Vyacheslav Kosorukovasuch therapy after surgical intervention can prevent the re -development of the tumor.

Russia announces a breakthrough in the fight against cancer

The development of “Enteromix” is the continuation of the efforts of Russian scientists in the field of oncology. Earlier in Dimitrovgrad it was reported to create new therapeutic vaccine against heavy forms of cancer.

Russia intends to make a vaccine free for their citizens. The selection of the first volunteers began in December 2024: patients with them can become solid tumorsnot related to blood diseases, and only after passing all standard treatment methods.

Scientific cooperation

The work is carried out jointly by the Hamalea Center, the Institute of Oncology. P.A. Herzen and the Center for Oncology. N.N. Blokhina.

Scientists promise that the new vaccine will become free and affordable For Russian citizens.

Source link